Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-22-004600
Filing Date
2022-05-05
Accepted
2022-05-05 09:18:54
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 55938
2 GRAPHIC g287237snap0002.jpg GRAPHIC 3089
  Complete submission text file 0000950123-22-004600.txt   61267
Mailing Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010
Business Address 345 PARK AVENUE SOUTH FLOOR 6 NEW YORK NY 10010 (212) 547-9879
Lexeo Therapeutics, Inc. (Filer) CIK: 0001907108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)